TIME BioVentures
Signal active
Investment Firm
Overview
Time BioVentures is an early-stage life sciences and healthcare venture capital firm based in Southern California. They invest in therapeutics, diagnostics, research tools, and healthcare delivery innovations.
Highlights
Founded
2020
Industry
Venture Capital
Employees
1-10
Investment
7
Lead Investment
1
Exits
undefined
Stages
Late Stage Venture, Early Stage Venture, Seed
Investor Type
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
TIME BioVentures, established in 2020 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Seed investments across Financial Services, Venture Capital, Finance, FinTech, Cyber Security, Health Care, mHealth, Medical Device, Personal Health, Hospital. Their recent investments include Section 32, Triventures, Kennedy Lewis Investment Management, Mousse Partners, Commons Clinic. The highest investment round they participated in was $40.6B. Among their most notable exits are Section 32 and Triventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
TIME BioVentures has made 7 investments. Their most recent investment was on Oct 09, 2023, when Commons Clinic raised $19.5M.
TIME BioVentures has made 2 diversity investments. Their most recent diversity investment was on Oct 11, 2021, when DeepSight Technology raised $25.0M.
investments
7
Diversity investments
2
Lead investments
1
Number of exits
undefined
Investments
7
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Sep 12, 2022 | Phantom Neuro | Medical | 6.0M |
| Dec 15, 2022 | BillionToOne | Biotechnology | 48.5M |
| Oct 09, 2023 | Commons Clinic | Health Care | 19.5M |
| Mar 26, 2024 | - | - | 33.0M |
Exits
0
Funding Timeline
Funding rounds
7
Investors
0
Funds
1
Funding Rounds
7
TIME BioVentures has raised 7 rounds. Their latest funding was raised on Mar 26, 2024 from a Series C - Brightside Health round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Sep 12, 2022 | Seed Round - Phantom Neuro | - | 6.0M | - |
| Dec 15, 2022 | Series C - BillionToOne | - | 48.5M | - |
| Oct 09, 2023 | Series A - Commons Clinic | - | 19.5M | - |
| Mar 26, 2024 | Series C - Brightside Health | - | 33.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.